Accelevation (NASDAQ:ACCV) Stock Rated “Overweight” in New Coverage at JPMorgan Chase & Co.

Oct 27, 2026
accelevation-(nasdaq:accv)-stock-rated-“overweight”-in-new-coverage-at-jpmorgan-chase-&-co.

Research analysts at JPMorgan Chase & Co. started coverage on shares of Accelevation (NASDAQ:ACCV – Get Free Report) in a research note issued to investors on Monday, Briefing.com reports. The firm set an “overweight” rating and a $20.00 price target on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 61.55% from the company’s previous close.

Several other research analysts have also commented on the company. Barclays started coverage on Accelevation in a report on Monday. They set an “overweight” rating and a $20.00 price objective for the company. Bank of America began coverage on shares of Accelevation in a research report on Monday. They set a “buy” rating and a $20.00 target price for the company. Robert W. Baird started coverage on shares of Accelevation in a report on Monday. They issued an “outperform” rating and a $16.00 price target on the stock. The Goldman Sachs Group assumed coverage on Accelevation in a research report on Monday. They set a “buy” rating and a $22.00 price objective on the stock. Finally, Wall Street Zen raised Accelevation to a “hold” rating in a research note on Saturday, October 10th. Seven research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, Accelevation currently has an average rating of “Moderate Buy” and a consensus target price of $19.33.

Get Our Latest Stock Analysis on ACCV

Accelevation Stock Performance

Shares of NASDAQ:ACCV opened at $12.38 on Monday. Accelevation has a one year low of $11.58 and a one year high of $18.10.

Insider Activity at Accelevation

In other news, CEO Michael Rubiera acquired 200,000 shares of the firm’s stock in a transaction on Thursday, October 1st. The shares were purchased at an average price of $18.00 per share, for a total transaction of $3,600,000.00. Following the completion of the transaction, the chief executive officer owned 1,424,285 shares of the company’s stock, valued at $25,637,130. The trade was a 16.34% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Paul D. Donahue acquired 7,000 shares of the stock in a transaction dated Thursday, October 1st. The shares were purchased at an average cost of $18.00 per share, with a total value of $126,000.00. Following the completion of the purchase, the director owned 7,000 shares of the company’s stock, valued at approximately $126,000. The trade was a ∞ increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders purchased a total of 227,700 shares of company stock worth $4,098,600 over the last ninety days.

Accelevation Company Profile

(Get Free Report)

Accelevation Corporation NASDAQ: ACCV is a special purpose acquisition company (SPAC) formed to identify and combine with an operating business through a merger, share exchange, asset acquisition, reorganization or similar transaction.

Unlike an operating company, Accelevation does not manufacture products, provide ongoing commercial services or conduct significant business activities of its own. Its primary activities have consisted of evaluating potential acquisition targets and pursuing a business combination.

Public information about Accelevation’s operating history, geographic footprint and leadership is limited.

Featured Articles

Analyst Recommendations for Accelevation (NASDAQ:ACCV)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Accelevation Right Now?

Before you consider Accelevation, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Accelevation wasn’t on the list.

While Accelevation currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Leave a comment